Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Amino Acids

• Publication date

  2017-07-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00726-017-2464-8PMID 28710551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients

  2018cited by this paper
• Abnormal expressions of AGEs, TGF-β1, BDNF and their receptors in diabetic rat colon–Associations with colonic morphometric and biomechanical remodeling

  2018cited by this paper
• Short-term effects of dietary advanced glycation end products in rats.

  2016cited by this paper
• Cross-linking versus RAGE: How do high molecular weight advanced glycation products induce cardiac dysfunction?

  2016cited by this paper
• Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan

  2015cited by this paper
• Role of advanced glycation end products in cellular signaling

  2014cited by this paper
• Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications

  2014cited by this paper
• Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling

  2014cited by this paper
• Advanced glycation end-products and cathepsin cysteine protease in type 2 diabetic patients.

  2013cited by this paper
• Advanced glycation endproducts in food and their effects on health.

  2013cited by this paper
• Advanced glycation endproducts in diabetes and diabetic complications.

  2013cited by this paper
• Diastolic Dysfunction of Aging Is Independent of Myocardial Structure but Associated with Plasma Advanced Glycation End-Product Levels

  2012cited by this paper
• Role of advanced glycation end products in cardiovascular disease.

  2012cited by this paper
• The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.

  2012cited by this paper
• Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling

  2012cited by this paper
• Receptor for Advanced Glycation End Products (RAGE) and Implications for the Pathophysiology of Heart Failure

  2012cited by this paper
• Advanced Glycation Endproduct Crosslinking in the Cardiovascular System

  2012cited by this paper
• Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.

  2012cited by this paper
• Dietary intake increases serum levels of carboxymethil-lysine (CML) in diabetic patients.

  2012cited by this paper
• Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome

  2011cited by this paper
• Transport of Free and Peptide‐Bound Glycated Amino Acids: Synthesis, Transepithelial Flux at Caco‐2 Cell Monolayers, and Interaction with Apical Membrane Transport Proteins

  2011cited by this paper
• AGE restriction in diabetes mellitus: a paradigm shift

  2011cited by this paper
• Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium

  2010cited by this paper
• Advanced glycation end products in foods and a practical guide to their reduction in the diet.

  2010cited by this paper
• Dietary Advanced Glycation End Products and Aging

  2010cited by this paper
• Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis.

  2010cited by this paper
• Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy.

  2010cited by this paper
• Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice

  2009cited by this paper
• The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease

  2009cited by this paper
• Soluble forms of RAGE in internal medicine

  2009cited by this paper
• Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients.

  2009cited by this paper
• Advanced Glycation and ROS: a link between diabetes and heart failure.

  2008cited by this paper
• RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium

  2008cited by this paper
• RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.

  2008cited by this paper
• The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient

  2007cited by this paper
• Advanced glycation end‐products (AGEs) and heart failure: Pathophysiology and clinical implications

  2007cited by this paper
• High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.

  2007cited by this paper
• Advanced glycation endproducts: what is their relevance to diabetic complications?

  2007cited by this paper
• Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes.

  2007cited by this paper
• Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin.

  2007cited by this paper
• Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes.

  2006influential reference
• Advanced glycation end products: sparking the development of diabetic vascular injury.

  2006cited by this paper
• Diets rich in Maillard reaction products affect protein digestibility in adolescent males aged 11-14 y.

  2006cited by this paper
• Receptor for Advanced-Glycation End Products: Key Modulator of Myocardial Ischemic Injury

  2006cited by this paper
• Advanced glycation endproducts--role in pathology of diabetic complications.

  2005cited by this paper
• Low‐Molecular Weight Advanced Glycation End Products: Markers of Tissue AGE Accumulation and More?

  2005cited by this paper
• The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.

  2005cited by this paper
• Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes

  2005cited by this paper
• Studies on Absorption and Elimination of Dietary Maillard Reaction Products

  2005cited by this paper
• Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes.

  2004cited by this paper
• Advanced glycoxidation end products in commonly consumed foods.

  2004cited by this paper
• Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation

  2004cited by this paper
• Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase.

  2004cited by this paper
• Fructose‐mediated non‐enzymatic glycation: sweet coupling or bad modification

  2004cited by this paper
• Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum

  2004cited by this paper
• Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease.

  2004cited by this paper
• Diketopyridylryanodine Has Three Concentration-dependent Effects on the Cardiac Calcium-release Channel/Ryanodine Receptor*

  2003cited by this paper
• Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels.

  2003cited by this paper
• Serum levels of low molecular weight advanced glycation end products in diabetic subjects

  2003cited by this paper
• Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.

  2003cited by this paper
• AGEs in foods: do they play a role in uremia?

  2003cited by this paper
• Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes

  2003cited by this paper
• Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes.

  2002cited by this paper
• Advanced glycation end-products: a review

  2001cited by this paper
• Glycated proteins in diabetes.

  2001cited by this paper
• Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.

  2000cited by this paper
• Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.

  2000cited by this paper
• THE CLINICAL SIGNIFICANCE OF GLYCATION

  1999cited by this paper
• Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.

  1999cited by this paper
• Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

  1999cited by this paper
• Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.

  1999cited by this paper
• Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

  1999cited by this paper
• Detection of Noncarboxymethyllysine and Carboxymethyllysine Advanced Glycation End Products (AGE) in Serum of Diabetic Patients

  1999cited by this paper
• Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.

  1998cited by this paper
• Glycated proteins in diabetes.

  1997cited by this paper
• Glycated proteins in diabetes.

  1997cited by this paper
• Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.

  1996cited by this paper
• Advanced protein glycosylation in diabetes and aging.

  1995cited by this paper
• Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction (*)

  1995cited by this paper
• Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.

  1994cited by this paper
• Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

  1991cited by this paper
• Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

  1989cited by this paper
• Reaction of glycolaldehyde with proteins: latent crosslinking potential of alpha-hydroxyaldehydes.

  1983cited by this paper
• Metabolic transit of early and advanced Maillard products.

  1981cited by this paper

• Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications

  2025cites this paper
• Hyperglycemia in the focus of prevention of age-related skin changes

  2025cites this paper
• The Role of Advanced Glycation End-Products in the Pathophysiology and Pharmacotherapy of Cardiovascular Disease

  2025influential citation
• Effect of the Chilean Bean Landrace Peumo on Metabolic Syndrome‐Related Parameters in C57BL/6 Mice Fed With a High‐Fat Diet

  2025cites this paper
• Assessing the relationship between short-term blood pressure variability and glycation profile in young and middle-aged nondiabetic hypertensive individuals

  2025cites this paper
• Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments.

  2024cites this paper
• Üniversite Öğrencilerinin Diyetle İleri Glikasyon Son Ürünleri (dAGE) Alımlarının Vücut Kompozisyonu ile İlişkisi

  2024cites this paper
• Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses

  2024cites this paper
• The inhibitory effects of endophytic metabolites on glycated proteins under non-communicable disease conditions: A review.

  2024cites this paper
• Moderate-Intensity and High-Intensity Interval Exercise Training Offer Equal Cardioprotection, with Different Mechanisms, during the Development of Type 2 Diabetes in Rats

  2024cites this paper
• Advanced Glycation End-Products and Their Effects on Gut Health

  2023cites this paper
• Accumulation of advanced glycation end products in skin and increased vascular ageing in the general population: the Malmö Offspring Study

  2023cites this paper
• Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats

  2023cites this paper
• Flavonoids improve type 2 diabetes mellitus and its complications: a review

  2023cites this paper
• Effects of advanced glycation end products (AGEs) on the differentiation potential of primary stem cells: a systematic review

  2023cites this paper
• Risk factors of severe periodontitis in kidney transplant recipients: A case-control study.

  2023cites this paper
• Advanced glycation end products are associated with cardiovascular risk in the Mexican population.

  2023cites this paper
• carbonate-Rich Mineral Water on Cardiometabolic Markers and Electrolytes in Rats With Streptozotocin-Induced Diabetes The Effects of Subchronic Intake of Magnesium Hydro-This

  2022cites this paper
• High serum levels of CML are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery

  2022cites this paper
• The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease

  2022cites this paper
• Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs

  2022cites this paper
• Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus

  2022cites this paper
• Accumulation of Advanced Glycation End Products Independently Increases the Risk of Hospitalization Among Hemodialysis Patients

  2022cites this paper
• Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis

  2022cites this paper
• AGEs–RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure

  2022cites this paper
• High serum levels of N-epsilon-carboxymethyllysine are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery

  2022cites this paper
• Exercise, Advanced Glycation End Products, and Their Effects on Cardiovascular Disorders: A Narrative Review

  2022cites this paper
• The effects of subchronic intake of magnesium hydro-carbonate-rich mineral water on cardiometabolic markers and electrolytes in rats with streptozotocin-induced diabetes

  2022cites this paper
• Evaluation of Major Constituents of Medicinally Important Plants for Anti-Inflammatory, Antidiabetic and AGEs Inhibiting Properties: In Vitro and Simulatory Evidence

  2022cites this paper
• Advanced Glycation End Products, Bone Health, and Diabetes Mellitus.

  2022cites this paper
• Relationship of advanced glycation end-products in hypertension in diabetic patients: a systematic review

  2022cites this paper
• Relação dos produtos finais de glicação avançada na hipertensão de pacientes com diabetes: uma revisão sistemática

  2022cites this paper
• Circulating and dietary advanced glycation end products and obesity in an adult population: A paradox of their detrimental effects in obesity

  2022cites this paper
• Acute Exposure to Glycated Proteins Impaired in the Endothelium-Dependent Aortic Relaxation: A Matter of Oxidative Stress

  2022influential citation
• Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products

  2022cites this paper
• Fluorescent advanced glycation end products in type 2 diabetes and its association with diabetes duration, hemoglobin A1c, and diabetic complications

  2022cites this paper
• Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients

  2021cites this paper
• Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis

  2021cites this paper
• Integrated Strategy for Discovery and Validation of Glycated Candidate Biomarkers for Hemodialysis Patients with Cardiovascular Complications.

  2021cites this paper
• ASSOCIATION BETWEEN ADVANCED GLYCATION END PRODUCTS AND INTAKE OF DIFFERENT TYPES OF BEVERAGES IN A HEALTHY POPULATION OF STUDENTS

  2021cites this paper
• Methods to investigate advanced glycation end-product and their application in clinical practice.

  2021cites this paper
• Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)

  2021cites this paper
• Profilin-1 is involved in macroangiopathy induced by advanced glycation end products via vascular remodeling and inflammation

  2021cites this paper
• Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers

  2021cites this paper
• Coronary Large Conductance Ca2+-Activated K+ Channel Dysfunction in Diabetes Mellitus

  2021cites this paper
• Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors

  2021cites this paper
• Advanced Glycation End Products Impair Cardiac Atrial Appendage Stem Cells Properties

  2021cites this paper
• Novel advances in inhibiting advanced glycation end product formation using natural compounds.

  2021cites this paper
• Nuclear Factor Kappa-B/Homeobox A9-Mediated Modulation of Leucine-Rich Repeat Flightless-Interacting Protein 1 Is Involved in Advanced Glycation End Product-Induced Endothelial Dysfunction

  2021cites this paper
• Effect of Photomodulation Therapy on Development of Oxidative Stress in Blood Leukocytes of Rats with Streptozocin-Induced Diabetes Mellitus

  2020cites this paper
• Beta carotene protects H9c2 cardiomyocytes from advanced glycation end product-induced endoplasmic reticulum stress, apoptosis, and autophagy via the PI3K/Akt/mTOR signaling pathway

  2020influential citation
• The cytotoxicity of advanced glycation end products was attenuated by UCMSCs in human vaginal wall fibroblasts by inhibition of an inflammatory response and activation of PI3K/AKT/PTEN.

  2020cites this paper
• Characterization of bromelain indicates a molar excess of inhibitor vs. enzyme molecules, a Jacalin-like lectin and Maillard reaction products.

  2020cites this paper
• The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review

  2020cites this paper
• Improvement of cardiac ventricular function by magnesium treatment in chronic streptozotocin-induced diabetic rat heart.

  2020cites this paper
• Effect of Photomodulation Therapy on Development of Oxidative Stress in Blood Leukocytes of Rats with Streptozocin-Induced Diabetes Mellitus

  2020cites this paper
• Is the Oxidative Stress in Obstructive Sleep Apnea Associated with Cardiovascular Complications?—Systematic Review

  2020cites this paper
• Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac pressure overload

  2020cites this paper
• Acute exposure to glycated proteins reduces cardiomyocyte contractile capacity

  2019cites this paper
• Maternal Consumption of a Diet Rich in Maillard Reaction Products Accelerates Neurodevelopment in F1 and Sex-Dependently Affects Behavioral Phenotype in F2 Rat Offspring

  2019cites this paper
• Impaired calcium homeostasis via advanced glycation end products promotes apoptosis through endoplasmic reticulum stress in human nucleus pulposus cells and exacerbates intervertebral disc degeneration in rats

  2019cites this paper
• ADVANCED GLYCATION END PRODUCTS AND THEIR RECEPTORS IN CARDIOVASCULAR DISEASES

  2019cites this paper
• Impact of advanced glycation end products (AGEs) signaling in coronary artery disease.

  2019cites this paper
• Pro-oxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes.

  2019cites this paper
• Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients

  2018cites this paper
• Methylglyoxal modification hinders amyloid conversion of prion protein

  2018cites this paper
• Abnormal expressions of AGEs, TGF-β1, BDNF and their receptors in diabetic rat colon–Associations with colonic morphometric and biomechanical remodeling

  2018cites this paper
• Relationship Between Advanced Glycation End-Products and Cardiovascular Disease

  2018cites this paper
• Faculteit Geneeskunde en Levenswetenschappen School voor Levenswetenschappen master in de biomedische wetenschappen

  2018cites this paper
• Western diet given to healthy rats mimics the human phenotype of diabetic cardiomyopathy.

  2018cites this paper
• Ukrainian Journal of Nephrology and Dialysis

  year unknowncites this paper